Differential muscular glycogen clearance after enzyme replacement therapy in a mouse model of Pompe disease
- 31 August 2007
- journal article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 91 (4), 343-351
- https://doi.org/10.1016/j.ymgme.2007.04.018
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe diseaseLaboratory Investigation, 2006
- Carbohydrate-remodelled acid α-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe miceBiochemical Journal, 2005
- Replacing acid α-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibersMolecular Therapy, 2005
- Twenty-two novel mutations in the lysosomal ?-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type IIHuman Mutation, 2003
- Enzyme replacement therapy in the mouse model of Pompe diseaseMolecular Genetics and Metabolism, 2003
- Glycogen Stored in Skeletal but Not in Cardiac Muscle in Acid α-Glucosidase Mutant (Pompe) Mice Is Highly Resistant to Transgene-Encoded Human EnzymeMolecular Therapy, 2002
- Acid a-Glucosidase Deficiency (Glycogenosis Type II, Pompe Disease)Current Molecular Medicine, 2002
- Identification of two subtypes of infantile acid maltase deficiencyThe Journal of Pediatrics, 2000
- Targeted Disruption of the Acid α-Glucosidase Gene in Mice Causes an Illness with Critical Features of Both Infantile and Adult Human Glycogen Storage Disease Type IIPublished by Elsevier BV ,1998
- α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease)Biochemical Journal, 1963